Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

GE HealthCare Technologies (GEHC) EBITDA Margin (2022 - 2025)

GE HealthCare Technologies' EBITDA Margin history spans 4 years, with the latest figure at 14.51% for Q4 2025.

  • For the quarter ending Q4 2025, EBITDA Margin fell 55.0% year-over-year to 14.51%, compared with a TTM value of 13.4% through Dec 2025, up 5.0%, and an annual FY2025 reading of 13.4%, up 5.0% over the prior year.
  • EBITDA Margin for Q4 2025 was 14.51% at GE HealthCare Technologies, up from 12.7% in the prior quarter.
  • The five-year high for EBITDA Margin was 15.74% in Q4 2022, with the low at 11.61% in Q1 2024.
  • Average EBITDA Margin over 4 years is 13.19%, with a median of 13.11% recorded in 2025.
  • Year-over-year, EBITDA Margin tumbled -250bps in 2023 and then skyrocketed 182bps in 2024.
  • Tracing GEHC's EBITDA Margin over 4 years: stood at 15.74% in 2022, then dropped by -16bps to 13.23% in 2023, then rose by 14bps to 15.06% in 2024, then dropped by -4bps to 14.51% in 2025.
  • Per Business Quant, the three most recent readings for GEHC's EBITDA Margin are 14.51% (Q4 2025), 12.7% (Q3 2025), and 13.06% (Q2 2025).